Blue Trust’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.16K Sell
3,142
-93
-3% -$324 ﹤0.01% 1729
2026
Q2
$11.3K Hold
3,235
– – ﹤0.01% 1839
2026
Q1
$9.32K Sell
3,235
-1,481
-31% -$5.83K ﹤0.01% 1859
2025
Q4
$19.2K Sell
4,716
-1,790
-28% -$8.02K ﹤0.01% 1694
2025
Q3
$23.1K Sell
6,506
-13,014
-67% -$47K ﹤0.01% 1623
2025
Q2
$53.3K Sell
19,520
-6,397
-25% -$13.2K ﹤0.01% 1441
2025
Q1
$43.5K Sell
25,917
-13,910
-35% -$38.9K ﹤0.01% 1433
2024
Q4
$64.9K Buy
39,827
+26,698
+203% +$79.6K ﹤0.01% 1126
2024
Q3
$71.7K Buy
13,129
+12,154
+1,247% +$63.8K ﹤0.01% 1402
2024
Q2
$9.8K Buy
+975
New +$7.77K ﹤0.01% 1934

Other funds holding SANA

Blue Trust's SANA Position: Q3 2026 in Review

Blue Trust reduced its Sana Biotechnology (SANA) stake by 2.9% in Q3 2026, selling an estimated $324 and leaving 3,142 shares worth $9.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

Blue Trust first reported a position in SANA in Q2 2024 and has held it in 10 quarters since. The position peaked at $71.7K in Q3 2024. 156 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Blue Trust held 3,142 shares of Sana Biotechnology worth $9.16K as of Q3 2026.
  • Blue Trust sold 93 Sana Biotechnology shares in Q3 2026, an estimated $324.
  • Sana Biotechnology made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1729 holding.
  • Blue Trust first reported a position in Sana Biotechnology in Q2 2024 and has held it in 10 quarters since.
  • Blue Trust's Sana Biotechnology position peaked at $71.7K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.